Aarush Manchanda is a Cardiology physician. OpenAlex indexes 6 publications with 211 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
30 Garden Ct Ste B
Monterey, CA 93940
Telephone
831-647-1123Registry record last updated 12 Mar 2019.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- E.R. Squibb & Sons, L.L.C.Program year20242 payments
- HeartFlow, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.1%Statin21.9%Rosuvastatin Calcium62%Atorvastatin Calcium29%Pravastatin Sodium6%Simvastatin3%Part D<11 patientsBeta blocker21.3%Metoprolol Succinate64%Metoprolol Tartrate19%Carvedilol11%Atenolol4%Nebivolol Hcl2%Part D<11 patients+ 14 more classes in this area
Blood & clotting
10.4%Factor Xa inhibitor7.2%Eliquis93%Xarelto7%Part D<11 patientsP2Y12 inhibitor2.4%Clopidogrel100%Part D≥29 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.6%Potassium supplement2%Potassium Chloride100%Part D≥18 patientsSGLT2 inhibitor0.9%Jardiance100%Part D≥14 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Management of refractory angina pectoris.
PubMed
2011 - Postępowanie w opornej na leczenie dławicy piersiowej
Via Medica Journals
2011 - Novel variant of dual left anterior descending coronary artery
Journal of cardiovascular computed tomography
2010 - Abstract 2414: Enhanced External Counterpulsation Therapy Improves Angina and Functional Status in Patients with Severe Left Ventricular Systolic Dysfunction2008
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”